Clinical trial Recruiting at 1 site Observational Ages 18 to 49

Detailed health profiling for people with PCOS

Official title: Phenotyping of Patients With Polycystic Ovary Syndrome (PCOS) in Alsace, France

Run by University Hospital, Strasbourg, France · NCT07339930 · Data updated 2026-11-12

This effort will collect clinical, hormonal (including AMH), and imaging information from adult women seen at Strasbourg University Hospital with suspected or confirmed PCOS to try to better define PCOS types.

Quick facts

Study typeObservational
Ages18 Years to 49 Years
SexAll
Enrollment100 (estimated)
SponsorUniversity Hospital, Strasbourg, France
Academic / other
Locations1 site (Strasbourg)
StatusRecruiting
StartedSeptember 17, 2025
Main results expectedSeptember 2026
Study endsSeptember 17, 2026
Registry record updatedJanuary 14, 2026
Trial IDNCT07339930 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adult women aged 18 to under 50 who consult the Endocrinology department at Strasbourg University Hospital with suspected PCOS or who are found to have PCOS during evaluation.

Probably not a fit

People whose final diagnosis excludes PCOS, those younger than 18 or 50 and older, and those unable to attend CHU de Strasbourg appointments will not directly benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational project will enroll adult women (18–49 years) who consult the Endocrinology department at CHU de Strasbourg for suspected PCOS or are found to have PCOS during endocrine care. Participants will have standardized collection of medical history, menstrual and reproductive data, hormone measurements including anti-Müllerian hormone (AMH), pelvic ultrasound morphology, and screening for metabolic risk and mood symptoms. No treatments are given as part of the protocol; data will be analyzed to identify clinical and biochemical phenotypes and how they relate to current diagnostic criteria. The aim is to reduce diagnostic delay and clarify feature clusters that could guide more personalized management in the future.

Why it matters

Potential benefit: If successful, this could help clinicians diagnose PCOS earlier and tailor care to specific PCOS subtypes, potentially improving fertility and metabolic management.

How similar studies have gone: Numerous prior observational cohorts have characterized PCOS phenotypes and supported AMH and ultrasound as useful markers, so this study builds on established but still-evolving evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult woman (≥18 years and \<50 years)
* Subject who consulted at the Strasbourg University Hospitals for suspected PCOS or for any other endocrinological condition that led to the discovery of PCOS.

Exclusion Criteria:

* Final diagnosis excluding PCOS.

Where it's running

  • ervice d'Endocrinologie, Diabétologie et Nutrition - CHU de Strasbourg - France
    Strasbourg, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Using LC-MS/MS to profile androgens for PCOS diagnosis

    This study tests whether LC-MS/MS measurement of androgen profiles can help diagnose PCOS in women compared with healthy controls.

    Recruiting Women's Hospital School Of Medicine Zhejiang University · Hangzhou, Zhejiang · NCT07916909

  • Brown adipose tissue responses in PCOS with infrared thermography and inositol

    This study tests whether brown fat activity, measured by infrared skin temperature and UCP-1 levels, differs among women with PCOS (normal weight or overweight/obese) and healthy controls, and whether 12 weeks of inositol changes those responses in overweight/obese PCOS participants.

    Recruiting at 2 sites Istanbul Health and Technology University · Istanbul and 1 other locations · NCT07896642

  • Risk tool for blood-clotting problems in adolescents and women with PCOS

    This project will try to build a risk model to spot decreased protein C or S and other clotting abnormalities in females aged 14–45 who have PCOS.

    Recruiting Guangdong Women and Children Hospital · Guangzhou, Guangdong · NCT07571096

  • Polycystic Ovary Syndrome in Type 1 Diabetes

    This study tests whether women with type 1 diabetes and PCOS differ from other groups in factors that drive androgen excess and what that means for health.

    Recruiting Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal · Madrid, Madrid · NCT07490964

  • PPOS versus GnRH antagonist IVF protocols for women with PCOS

    This trial will test whether a progestin-primed ovarian stimulation (PPOS) protocol or a GnRH antagonist protocol gives better IVF outcomes for women aged 18–40 with PCOS.

    Recruiting Hanoi General Hospital (Vietnam) · Hanoi, Hanoi · NCT07394530

  • Tirzepatide for improving reproductive function and metabolic health in overweight women with PCOS

    We will test whether tirzepatide can improve menstrual regularity and metabolic health in premenopausal women with PCOS who are overweight or have obesity.

    Recruiting Phase 4 University of Bonn · Bochum and 1 other locations · NCT07326111

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.